Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
TrialStat is a data and operations platform for clinical trials, built around a unified eClinical Suite. Its target users include pharmaceutical companies, biotech firms, medical device/diagnostics companies, CROs, and data management organizations. It supports pilot studies, proof-of-concept work, Phase I–IV trials, and medical device studies. This is not a general-purpose SaaS product, but clinical research infrastructure designed for highly regulated environments.
Based on the available content, TrialStat’s main strength is its integrated modular design: EDC, eConsent, Randomization/IWRS, ePRO/eCOA, medical coding, AE/SAE safety event management, VNA imaging archiving, reporting and analytics, and a clinical data warehouse are all part of the same system. The EDC supports customizable eCRFs, edit checks, dynamic branching, real-time data visualization, 40+ standard reports, and configurable dashboards. eConsent supports witnesses, assent, re-consent, consent withdrawal, multimedia, and multiple languages. ePRO is 100% web-based, with patient data flowing into the EDC in real time.
The platform emphasizes interoperability and can connect with EMR/EHR systems, medical wearables, laboratories, other EDC systems, CTMS, eTMF, safety systems, and more. It also provides comprehensive APIs and custom validation development services. For team collaboration, the materials mention scenarios such as single sign-on, multi-tenancy, Study Designer, Data Manager, Trial Manager, and site staff roles, but do not disclose a fine-grained permissions model. Compliance is a major focus: TrialStat states support for 21 CFR Part 11, HIPAA, GDPR, FISMA, SOX, and related requirements, along with electronic signatures, audit trails, change control, CAPA, and a quality management system.
The website does not publish plans or pricing, nor does it provide information about a free tier or self-service trial. Access appears to be primarily through a form-based request for a personalized demo. Deployment is described as hosted, with access via browsers and mobile devices, and no proprietary plugins or desktop installation required. No self-hosting option was found.
The advantages are a comprehensive set of clinical modules, reduced need to stitch together third-party systems, broad compliance coverage, and strong customizability. It is well suited to complex or multi-center clinical trials, decentralized trials, and studies that need imaging, randomization, patient-reported outcomes, and safety event workflows to work together. The drawbacks are limited pricing transparency, potentially high implementation complexity, and little relevance outside the life sciences sector.
The materials do not mention China-based infrastructure, ICP filing, RMB payments, or local support, so china_access can only be assessed as unknown. Chinese teams that require local compliance, Chinese-language service, and stable access from mainland China should verify network connectivity, cross-border data requirements, and payment methods before procurement, and compare TrialStat with Medidata, Omnicomm/DataTrack, and domestic Chinese EDC/eClinical vendors.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on trialstat.com official site.
trialstat.com is an Canada Health provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach trialstat.com directly.